• LVMH posted organic growth of 14% in Q3, albeit at a slower pace. The fashion & leather goods division grew by 9%, compared with 11.2% anticipated.
  • Veolia signs €2 billion waste management contract in Hong Kong.
  • Birkenstock shares placed at USD 46 apiece in New York IPO.
  • GSK reaches confidential settlement in California Zantac litigation.
  • Samsung Electronics advanced after a sharp fall in its quarterly results, but this signals that the worst may be over for the sector.
  • Exxon Mobil is paying over US$250 per share for Pioneer Natural Resources.
  • BP Plc raises its Ebitda forecast for 2030.
  • UK regulator launches in-depth investigation into Arcelik's European agreement with Whirlpool.
  • Eni and partners to decide on LNG investment in Mozambique by mid-2024.
  • Walgreens Boots Alliance appoints Tim Wentworth as CEO.
  • Boeing struggles to keep pace with aircraft deliveries this year.
  • Apple will roll out update for iPhone 12.
  • FirstGroup raises its annual earnings outlook.
  • KKR plans to sell Q-Park for $4.2 bn.
  • Novo Nordisk prematurely terminates Ozempic trial for the treatment of renal failure.
  • Advanced Micro Devices signs agreement to buy artificial intelligence software company Nod.ai.
  • Big Yellow raises £110 million to continue building its stores.
  • Roche publishes new positive data on subcutaneous injection of Ocrevus.
  • Aker Carbon Capture wins feasibility study for biomass combined heat and power plant in Germany.
  • HP Inc - The computer manufacturer announced Tuesday that it expects overall earnings for the current fiscal year to be in line with expectations, and has decided to raise its annual dividend. 
  • Eli Lilly - The pharmaceutical group gained 2.5% in premarket trading in the wake of Novo Nordisk, which announced its intention to prematurely terminate a clinical trial on Ozempic due to signs showing the treatment's efficacy in diabetes.
  • Walgreens Boots Alliance - The drugstore chain announced on Tuesday that it had appointed Tim Wentworth as Chief Executive Officer, effective October 23, one month after the surprise resignation of Rosalind Brewe. 
  • Illumina is expected to get the green light from the European Commission on Thursday to sell cancer screening test maker GRAIL, after imposing a record €432 million fine on the US biotech company in July for completing its $7.1 billion takeover of Grail despite a veto from European authorities a year ago, a source with direct knowledge of the matter said on Tuesday.
  • Chevron - The oil company has made progress in negotiations with unions representing employees at its two liquefied natural gas (LNG) sites in Australia, a union representative said.
  • General Motors - The automaker reached a tentative agreement with Canadian union Unifor, just hours after strikes began at three plants.
  • Blackstone - The private equity firm is in preliminary discussions to acquire a stake in the Indian arm of Walt Disney, two sources familiar with the matter told Reuters on Wednesday.
  • Humana announced that its long-serving CEO Bruce Broussard will step down in the second half of 2024. He will be replaced by Jim Rechtin.
  • Ally Financial fell after the group's announcement that its CEO Jeffrey Brown will leave early next year.